Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration.
Saved in:
| Title: | Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration. |
|---|---|
| Authors: | Hang A; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Ngo T; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Virk JS; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Moussa K; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Moshiri A; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Emami-Naeini P; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA., Park SS; Department of Ophthalmology & Vision Science, University of California Davis Eye Center, Sacramento, CA, USA. |
| Source: | Clinical ophthalmology (Auckland, N.Z.) [Clin Ophthalmol] 2024 Dec 14; Vol. 18, pp. 3781-3789. Date of Electronic Publication: 2024 Dec 14 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101321512 Publication Model: eCollection Cited Medium: Print ISSN: 1177-5467 (Print) Linking ISSN: 11775467 NLM ISO Abbreviation: Clin Ophthalmol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
